Source: Annual Congress 2004 - Noninfectious pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Nakashima, A. Yokoyama, H. Ohnishi, Y. Ohnari, N. Shiota, H. Hamada, K. Kondo, M. Miyazaki, M. Nakajima, H. Maeda, N. Kohno (Hiroshima, Onsen-gun, Japan). Circulating MUC1 is associated with thrombophilic state in lung diseases. Eur Respir J 2004; 24: Suppl. 48, 3156

Member's Comments

No comment yet.

Related content which might interest you: Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020 Year: 2020 Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019 The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Circulating adhesion molecules as prognostic markers in childhood asthma Source: Eur Respir J 2004; 24: Suppl. 48, 160s Year: 2004 Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Cytokines status, endothelial function in patients with pulmonary diseases Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Circulating fibrocytes in interstitial lung disease Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Elevated neutrophil lymphocyte ratio and T4 levels can be predisposing factors for silicosis Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Lung cancer and associated diseases Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008